Therapeutic advances in RRMM: What is the latest on practical application of BCMA-directed therapies?

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care. The experts Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands Dr Francesca Gay, University of Torino, Italy This touchPODCAST is for HCPs outside of the USA. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com 

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice. The experts: Dr Ike K Ahmed, Prism Eye Institute, Toronto, ON, Canada; John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA Dr David F Chang, University of California, San Francisco, CA, USA; Altos Eye Physicians, Los Altos, CA, USA Dr Jennifer Loh, Loh Ophthalmology Associates, Miami, FL, USA This touchPODCAST is for HCPs in the USA, Latin America and Canada only. This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchophthalmologyime.org/phacoemulsification-cataract-surgery/    

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accurately and promptly diagnose the condition, and reviews supportive care strategies to maximize patients’ functional vision and improve their wellbeing.  The expert: Prof. Elias Traboulsi, Cleveland Clinic, Cleveland, OH, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com

touchTALKS for touchENDOCRINOLOGY  Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sherr also explores strategies for prevention and early intervention plus the advantages, drawbacks and recent developments in ketone monitoring. The experts Prof. Jennifer Sherr, Yale School of Medicine, New Haven, CT, US This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.  For further information visit our website:  www.touchENDOCRINOLOGY.com

touchCASES for touchRESPIRATORY and touchCARDIO This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial diagnosis and risk stratification to treatment initiation and escalation. The experts: Dr Athénaïs Boucly, University of Paris-Saclay, Le Kremlin-Bicêtre, Paris, France Prof. Pilar Escribano Subìas, Complutense University of Madrid, Spain This touchPODCAST is for HCPs outside the UK This activity is provided by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider For further information, visit our websites: www.touchRESPIRATORY.com and www.touchCARDIO.com

touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effective use. The experts: Dr Eden Miller, Diabetes and Obesity Care, Bend, OR, USA Dr Ian J Neeland, Case Western Reserve University, and Harrington Heart and Vascular Institute, University Hospitals Cleveland, OH, USA This activity is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchCARDIO.com and www.touchENDOCRINOLOGY.com

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches. The experts Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium Prof. Florian Lordick, University of Leipzig, Leipzig, Germany This touchPODCAST is for HCPs outside of the UK This activity is funded by an independent medical education grant from AstraZeneca.  This activity is jointly provided by USF Health and touchIME.  touchIME is an EBAC® accredited provider.  For further information visit our website:  www.touchONCOLOGY.com 

touchPANEL DISCUSSION for touchONCOLOGY Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies. The experts Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/panel-icis-in-ec/ 

touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at improving patient outcomes. The expert: Dr Chafic Karam, University of Pennsylvania, Philadelphia, PA, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our websites:  https://touchneurology.com/ and https://touchcardio.com/

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Moreau Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below Clinical themes Approved BCMA-directed therapeutic approaches  Practical application of BCMA-directed therapies Future of treating RRMM: Emerging BCMA-directed therapies and combinations The internationally renowned multiple myeloma expert faculty Prof. Philippe Moreau: Nantes, France Prof. Hermann Einsele: Würzburg, Germany Dr Paola Neri: Calgary, AB, Canada This touchPODCAST is for HCPs outside of the USA.  This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com